Steward Partners Investment Advisory, LLC Viking Therapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 129,923 shares of VKTX stock, worth $8.18 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
129,923
Previous 84,273
54.17%
Holding current value
$8.18 Million
Previous $6.91 Million
0.33%
% of portfolio
0.07%
Previous 0.08%
Shares
14 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$636 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$379 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$322 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$142 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$117 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.83B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...